Showing results (171-180 of 1,286) with videos related to
Sort By:
Pageof 129
Journal of Cardiovascular Pharmacology and Therapeutics|February 6, 2010
Cardioprotection with adenosine-regulating agent, GP531: effects on no-reflow, infarct size, and blood flow following ischemia/ reperfusion in the rabbitSharon L Hale, Robert A KlonerJournal of Cardiovascular Pharmacology and Therapeutics|December 31, 2005
Sarcoplasmic reticulum adenosine triphosphatase overexpression in the L-type Ca2+ channel mouse results in cardiomyopathy and Ca2+ -induced arrhythmogenesisMarta Rubio, Ilona Bodi, Geraldine A Fuller-Bicer, et al.Journal of Cardiovascular Pharmacology and Therapeutics|May 26, 2018
The Association Between β-Blocker Use and Cardiorespiratory Fitness: The Maastricht StudyJohannes T H Nielen, Frank de Vries, Jeroen H P M van der Velde, et al.Journal of Cardiovascular Pharmacology and Therapeutics|May 23, 2018
The Utility of Anti-Inflammatory Agents in Cardiovascular Disease: A Novel Perspective on the Treatment of AtherosclerosisSanthosh J Kottoor, Rohit R AroraJournal of Cardiovascular Pharmacology and Therapeutics|May 22, 2018
Regression of Atherosclerotic Plaques of Cholesterol-Fed Rabbits by Combined Chemotherapy With Paclitaxel and Methotrexate Carried in Lipid Core NanoparticlesFernando L T Gomes, Raul C Maranhão, Elaine R Tavares, et al.Journal of Cardiovascular Pharmacology and Therapeutics|May 12, 2017
Drug-Induced Takotsubo CardiomyopathyKazuhiko Kido, Maya GuglinJournal of Cardiovascular Pharmacology and Therapeutics|April 14, 2018
Efficacy and Safety of S-Amlodipine 2.5 and 5 mg/d in Hypertensive Patients Who Were Treatment-Naive or Previously Received Antihypertensive MonotherapySelçuk Şen, Meral Demir, Zerrin Yiğit, et al.Journal of Cardiovascular Pharmacology and Therapeutics|January 8, 2010
L-arginine as a nutritional prophylaxis against vascular endothelial dysfunction with agingKevin S Heffernan, Christopher A Fahs, Sushant M Ranadive, et al.Journal of Cardiovascular Pharmacology and Therapeutics|February 28, 2009
Dose-dependent effect of rosuvastatin treatment on HDL-subfraction phenotype in patients with primary hyperlipidemiaMichael S Kostapanos, Haralampos J Milionis, Theodosios D Filippatos, et al.Journal of Cardiovascular Pharmacology and Therapeutics|October 8, 2005
Tolvaptan administration does not affect steady state amiodarone concentrations in patients with cardiac arrhythmiasSusan Elizabeth Shoaf, Marcelo Víctor Elizari, Zhao Wang, et al.Pageof 129